Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Apr 2024 01:00 PM
RNS
Study unlocks insights into disease and longevity
12 Apr 2024 12:00 PM
RNS
LTIP and DBP; Director/PDMR Notification
11 Apr 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
08 Apr 2024 04:00 PM
RNS
Block Listing Interim Review
02 Apr 2024 02:00 PM
RNS
Issue of Equity and Total Voting Rights
28 Mar 2024 05:55 PM
RNS
Holding(s) in Company
12 Mar 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Mar 2024 07:00 AM
RNS
Oxford Nanopore to Present at Barclays Conference
08 Mar 2024 12:00 PM
RNS
Director/PDMR Shareholding
07 Mar 2024 07:00 AM
RNS
Director/PDMR Shareholding
06 Mar 2024 07:00 AM
RNS
FY23 Preliminary Results
01 Mar 2024 02:00 PM
RNS
Issue of Equity and Total Voting Rights
29 Feb 2024 06:00 PM
RNS
Directorate Change
13 Feb 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
02 Feb 2024 04:30 PM
RNS
Holding(s) in Company
01 Feb 2024 12:00 PM
RNS
Issue of Equity and Total Voting Rights
22 Jan 2024 07:00 AM
RNS
Expansion of leadership team
11 Jan 2024 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
11 Jan 2024 05:30 PM
RNS
Employee Stock Purchase Plan - PDMR Notification
09 Jan 2024 07:00 AM
RNS
FY23 trading update
03 Jan 2024 07:00 AM
RNS
Presentation at 42nd Annual J.P. Morgan Conference
02 Jan 2024 04:00 PM
RNS
Issue of Equity and Total Voting Rights
02 Jan 2024 04:00 PM
RNS
Director/PDMR Shareholding (ESPP)
19 Dec 2023 02:00 PM
RNS
Appointment of Two Non-Executive Directors
12 Dec 2023 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Dec 2023 04:30 PM
RNS
Nanopore Community Meeting Technology Update
01 Dec 2023 05:00 PM
RNS
Issue of Equity and Total Voting Rights
30 Nov 2023 07:00 AM
RNS
National Australian rare disease programme
13 Nov 2023 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
13 Nov 2023 12:00 PM
RNS
Participation in upcoming investor conferences
07 Nov 2023 08:30 AM
RNS
Admission to Trading on the London Stock Exchange
06 Nov 2023 07:00 AM
RNS
Issue of Equity
01 Nov 2023 04:00 PM
RNS
Issue of Equity and Total Voting Rights
31 Oct 2023 07:00 AM
RNS
Apple showcases Oxford Nanopore in M3 launch
26 Oct 2023 06:10 PM
RNS
Holding(s) in Company
24 Oct 2023 12:30 PM
RNS
Holding(s) in Company
23 Oct 2023 08:30 AM
RNS
Issue of Equity and Total Voting Rights
23 Oct 2023 08:30 AM
RNS
Admission to Trading on the London Stock Exchange
19 Oct 2023 07:00 AM
RNS
Mayo Clinic and Oxford Nanopore collaboration
19 Oct 2023 07:00 AM
RNS
bioMérieux makes investment in Oxford Nanopore
19 Oct 2023 07:00 AM
RNS
Capital Markets Day - ONT expands into clinical
11 Oct 2023 03:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
06 Oct 2023 03:00 PM
RNS
Block Listing Interim Review
02 Oct 2023 04:00 PM
RNS
Issue of Equity and Total Voting Rights
27 Sep 2023 05:00 PM
RNS
Director Declaration
27 Sep 2023 05:00 PM
RNS
Director Declaration
12 Sep 2023 03:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Sep 2023 07:00 AM
RNS
Presentation at the Morgan Stanley Conference
06 Sep 2023 07:00 AM
RNS
Interim results for the 6 months ended 30 June 23
01 Sep 2023 03:00 PM
RNS
Issue of Equity and Total Voting Rights
UK 100

Latest directors dealings